Start up: Supporting PAH patients beginning prostanoids
- Robyn Kalda
- Jun 1
- 1 min read
This study looked at a French support program designed to help people with pulmonary arterial hypertension (PAH) start and adjust their dose of selexipag. Nurses called patients three days after patients started treatment or changed doses to monitor side effects and provide guidance. Most patients were able to reach their best individual dose within about 11 weeks, and most side effects were mild or manageable. Both patients and healthcare providers reported very high satisfaction with the program, suggesting that extra support may help people stay on treatment successfully.
What I like most about Eggy Car is that every attempt feels different. You think you've mastered a hill, then one small mistake sends the egg flying.
I found Drive Mad to be one of those browser games that's easy to start but difficult to put down. Every failed attempt makes me want to try again.